Literature DB >> 16186452

A missed opportunity: hepatitis C screening of prisoners.

Grace E Macalino1, Darpun Dhawan, Josiah D Rich.   

Abstract

In 2003, the Centers for Disease Control and Prevention issued recommendations to screen all inmates with a history of injection drug use or other risk factors for hepatitis C. We compared self-reported risk factors for hepatitis C with serostatus from inmates in the Rhode Island Department of Corrections. Of the male inmates who were hepatitis C positive, 66% did not report injection drug use. Risk-based testing underestimates the hepatitis C virus (HCV) prevalence in correctional settings and limits the opportunity to diagnose and prevent hepatitis C infection.

Entities:  

Mesh:

Year:  2005        PMID: 16186452      PMCID: PMC1449429          DOI: 10.2105/AJPH.2004.056291

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  10 in total

1.  Adopting more systematic approaches to hepatitis C treatment in correctional facilities.

Authors:  Theodore M Hammett
Journal:  Ann Intern Med       Date:  2003-02-04       Impact factor: 25.391

2.  Treating prisoners with HIV/AIDS: the importance of early identification, effective treatment, and community follow-up.

Authors:  Catherine Crosland; Michael Poshkus; Josiah D Rich
Journal:  AIDS Clin Care       Date:  2002-08

3.  Prevalence and incidence of HIV, hepatitis B virus, and hepatitis C virus infections among males in Rhode Island prisons.

Authors:  Grace E Macalino; David Vlahov; Stephanie Sanford-Colby; Sarju Patel; Keith Sabin; Christopher Salas; Josiah D Rich
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

Review 4.  Self-reported drug use: results of selected empirical investigations of validity.

Authors:  Y I Hser
Journal:  NIDA Res Monogr       Date:  1997

Review 5.  Self-report among injecting drug users: a review.

Authors:  S Darke
Journal:  Drug Alcohol Depend       Date:  1998-08-01       Impact factor: 4.492

6.  Introduction--the validity of self-reported drug use: improving the accuracy of survey estimates.

Authors:  L Harrison; A Hughes
Journal:  NIDA Res Monogr       Date:  1997

7.  The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997.

Authors:  Theodore M Hammett; Mary Patricia Harmon; William Rhodes
Journal:  Am J Public Health       Date:  2002-11       Impact factor: 9.308

8.  The validity of drug use reports from juvenile arrestees.

Authors:  M Fendrich; Y Xu
Journal:  Int J Addict       Date:  1994-06

Review 9.  Testing for hepatitis C virus infection should be routine for persons at increased risk for infection.

Authors:  Miriam J Alter; Leonard B Seeff; Bruce R Bacon; David L Thomas; Michael O Rigsby; Adrian M Di Bisceglie
Journal:  Ann Intern Med       Date:  2004-11-02       Impact factor: 25.391

10.  Prevention and control of infections with hepatitis viruses in correctional settings. Centers for Disease Control and Prevention.

Authors:  Cindy Weinbaum; Rob Lyerla; Harold S Margolis
Journal:  MMWR Recomm Rep       Date:  2003-01-24
  10 in total
  25 in total

1.  Survey of US Correctional Institutions for Routine HCV Testing.

Authors:  Curt G Beckwith; Ann E Kurth; Lauri Bazerman; Liza Solomon; Emily Patry; Josiah D Rich; Irene Kuo
Journal:  Am J Public Health       Date:  2015-01       Impact factor: 9.308

2.  Estimating HCV prevalence at the state level: a call to increase and strengthen current surveillance systems.

Authors:  Rachel Hart-Malloy; Alvaro Carrascal; A Gregory Dirienzo; Colleen Flanigan; Kristi McClamroch; Lou Smith
Journal:  Am J Public Health       Date:  2013-06-13       Impact factor: 9.308

3.  Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings.

Authors:  Sarah Larney; Madeline K Mahowald; Nicholas Scharff; Timothy P Flanigan; Curt G Beckwith; Nickolas D Zaller
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

4.  A Budget Impact Analysis of Newly Available Hepatitis C Therapeutics and the Financial Burden on a State Correctional System.

Authors:  John T Nguyen; Josiah D Rich; Bradley W Brockmann; Fred Vohr; Anne Spaulding; Brian T Montague
Journal:  J Urban Health       Date:  2015-08       Impact factor: 3.671

5.  Correlates of Hepatitis C Virus Infection in the Targeted Testing Program of the New York City Jail System.

Authors:  Matthew J Akiyama; Fatos Kaba; Zachary Rosner; Howard Alper; Aimee Kopolow; Alain H Litwin; Homer Venters; Ross MacDonald
Journal:  Public Health Rep       Date:  2016-12-14       Impact factor: 2.792

6.  Hepatitis C Testing and Patient Characteristics in Washington State's Prisons Between 2012 and 2016.

Authors:  Sabrina A Assoumou; Jianing Wang; Abriana Tasillo; Golnaz Eftekhari Yazdi; Judith I Tsui; Lara Strick; Benjamin P Linas
Journal:  Am J Prev Med       Date:  2018-11-19       Impact factor: 5.043

Review 7.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

8.  "Seek, test, treat and retain" for hepatitis C in the United States criminal justice system.

Authors:  Sarah Larney; Curt G Beckwith; Nickolas D Zaller; Brian T Montague; Josiah Rich
Journal:  Int J Prison Health       Date:  2014

9.  HCV in incarcerated populations: an analysis of gender and criminality on risk.

Authors:  Anne G Rhodes; Faye S Taxman; Peter D Friedmann; Karen L Cropsey
Journal:  J Psychoactive Drugs       Date:  2008-12

Review 10.  Best strategies for global HCV eradication.

Authors:  Liesl M Hagan; Raymond F Schinazi
Journal:  Liver Int       Date:  2013-02       Impact factor: 5.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.